MAPK3 and neoplasm: In oncogenic signaling, activation of JNK (c‐Jun N‐terminal kinase), ERK1/2 (extracellular signal‐regulated kinase 1/2), and AKT (protein kinase B) plays a significant role in contributing to tumor development and progression [35].